3 hours agoGenk striker Samatta: Facing Liverpool a dream come true

first_imgAbout the authorPaul VegasShare the loveHave your say Genk striker Samatta: Facing Liverpool a dream come trueby Paul Vegas3 hours agoSend to a friendShare the loveRacingGenk striker Mbwana Ally Samatta admits facing Liverpool was a “dream come true”.Liverpool were comfortable 4-1 winners for Wednesday night’s Champions League encounter.And Tanzania international Samatta said: “As a child I was not a fan of Liverpool, but of the arch rival: Manchester United. “I’m not going to say that I get goose bumps, but it’s so special. “A game like this and to be allowed to play is like a dream, the dream of every boy watching football on television.” last_img read more

Read More

Ezekiel Elliott Just Trashed Jim Harbaugh On The Paul Finebaum Show

first_imgEzekiel elliott talks about Jim Harbaugh on the Paul Finebaum show.Jim Harbaugh was only Michigan’s head coach for one of the program’s three rivalry contests against Ohio State during Ezekiel Elliott’s tenure, but he seems to have made quite an impression on the star running back. Friday, Elliott, who is going through the ESPN car wash today, trashed Harbaugh, telling Paul Finebaum that he’s “tired” of hearing about him. Elliott also called out Harbaugh for talking smack when he hasn’t won a rivalry game. Yikes.“I’m tired of hearing about Coach Harbaugh he needs to get in check with reality” – @EzekielElliott pic.twitter.com/QHElXCl7QV— Paul Finebaum (@finebaum) April 15, 2016more from @EzekielElliott: “you can’t talk smack about a rivalry when you haven’t won a game. You have to win ballgames to talk behind it.”— Paul Finebaum (@finebaum) April 15, 2016Here’s @EzekielElliott‘s full quote about Jim Harbaugh on @finebaum pic.twitter.com/FkeSmMrqZa— John Hayes (@johnP_hayes) April 15, 2016This isn’t exactly a surprise – Elliott has made a living off of trolling Michigan the past few years. But it’s still hilarious, and reminds us that there is no better college football rivalry than Ohio State vs. Michigan.last_img read more

Read More

Cisco will use ANGA COM to highlight IP network tr

first_imgCisco will use ANGA COM to highlight IP network transformation, Gigabit services, cloud-powered video, service agility and security.Cisco will use the show to highlight the cBR-8, described by the company as the industry’s first DOCSIS 3.1/CCAP platform, already deployed with 90 operators on three continents.The platform delivers throughput of 10 Gigabits per second downstream, and 1Gbps upstream.Cisco will also showcase its remote PHY work to take fibre deeper, with different configurations of shelves and nodes to suit different architectural/topological implementations already in the field. The company has also developed a range of analogue nodes and amplifiers designed for DOCSIS 3.1 upgrades specifically designed for the European market.Cisco will also highlight its work on cable-specific Software-Defined Networking (SDN) virtualisation and orchestration, including SDN capabilities on the cBR8, to enable service velocity and to simplify operations.Cisco will also show its Pro-active Network Maintenance (PNM) solution that the company says allows operators to reduce operating expenditure by proactively detecting any network issues within an accuracy of 10 metres..The company will also demonstrate its Video Quality Monitoring (VQM) solution that continuously monitors the user experience from signal acquisition to playout, to any end device over any network. Cisco has teamed up with Skyline, Mariner and Nimble to build the VQM solution.To address immersive 4K video and HDR (High Dynamic Range) encoding, orchestration of cloud-based services, and open media distribution for CDNs, the company will showcase its V2P (Virtualized Video Processing) line, which blends Cisco and third party applications across cloud environments.Cisco will also showcase connected home technologies including its HomeGuard whole-home cyber-security protection.Cisco’s JT Taylor, senior manager, video marketing, will take part in a panel session at the Congress on June 7 about recommendations and the RDK (Reference Design Kit), while Yves Padrines, VP, global service provider EMEAR, will speak at 10:00 on the June 7 on personalised television. John Downey will speak on a panel about DOCSIS 3.1 on June 8 at 11:30; and Adam Davies, product marketing manager for Cisco’s Infinite Video line, will be speaking on a panel about multi-screen technologies on June 9 at 2:45.Cisco will exhibit at ANGA COM on Stand H21 in Hall 10.2.last_img read more

Read More

Ibrahim Eren Marcello Foa Giacomo Ghisani Serge

first_imgIbrahim Eren, Marcello Foa, Giacomo Ghisani, Sergei Pavlov and Gonçalo ReisEuropean public broadcasters organization the EBU has elected a new executive board, with nine executives from public media across the continent joining EBU president Tony Hall, director-general of the BBC, and vice-president Delphine Ernotte, director-general of France Télévisions.The other new members of the board are: Ibrahim Eren, director-general of Turkey’s TRT; Marcello Foa, the new president of Italy’s Rai; Giacomo Ghisani, acting director-general of Radio Vaticana; Sergei Pavlov, director of international relations and member of the board of directors of Channel One Russia; and Gonçalo Reis, president and CEO of Portugal’s RTP.Cilla Benkö of Sweden’s SR, Petr Dvořák of the Czech Republic’s CT, Ulrich Wilhelm of Germany’s ARD/BR and Gilles Marchand of Switzerland’s SRG SSR were all re-elected to serve a new term.Leaving the board are former president Jean-Paul Philippot of Belgium’s RTBF and former vice-president Monica Maggioni of Rai.Incoming president Hall said: “I welcome this new EBU executive board. Public service media has never been more important or more needed.  As we begin our EBU presidency in January, Delphine Ernotte Cunci and I look forward to working closely with the new Board and the EBU director-general Noel Curran, as well as with all EBU members and staff. It’s a time of great excitement and opportunity in global media. And I firmly believe that the time for public service media has come ­­– with brilliant local content, impartial news and a universal mission that brings us all together. Through working together I believe that EBU members can deliver even more for our audiences, and I’m excited about working with the new executive board to deliver that ambition over the two years ahead.”last_img read more

Read More

The Ulster History Circle also gained approval to

first_imgThe Ulster History Circle also gained approval to unveil a plaque at the Tower Museum to Mabel Remington Colhoun (1905 – 1992), Archaeologist, historian and educationalist.For further details on the Blue Plaque programme within the Derry City and Strabane District Council area visit www.derrystrabane.com.BLUE PLAQUE PROGRAMME LAUNCHED AT TOWER MUSEUM was last modified: April 28th, 2017 by John2John2 Tags: BLUE PLAQUE PROGRAMME LAUNCHED AT TOWER MUSEUM ShareTweetcenter_img A five year ‘Blue Plaque’ programme for the city and district was launched at the Tower Museum last night by the Ulster History Circle and Derry City and Strabane District Council following the unanimous approval of the project by Council’s Business and Culture committee members.Councillors agreed at the Council meeting to support a proposed five year programme plan for the erection of Blue Plaques by the Ulster History Circle in the Derry Strabane District Council area.A total of six candidates were presented for special recognition including; Francis Ledwidge (1887 – 1917) an Irish poet and soldier, killed in 1917 at Boezibnge in Belgium.Ledwidge was stationed for six months during 1916 in Ebrington Barracks with the Royal Inniskilling Fusiliers; Annie Russell Maunder (1868 – 1947), an Irish astronomer and mathematician, born in Strabane; Mrs E.H. O’Doherty, founder of the Féis Dhoíre Cholmcílle in the city; Brigadier General Ambrose Ricardo (1866 – 1923), who held a distinguished war record and cofounded the Londonderry Féis; Dorothy Parke (1904 – 1990), a teacher and composer whose pieces are still performed at the Féis, her collection of songs, ‘By Winding Roads’ remains popular in many primary schools, she was born on Dunfield Road, Londonderry.last_img read more

Read More

FDA and DOD sign MOU regarding medical product development and assessment

first_img In July 2018, the FDA granted an Emergency Use Authorization (EUA) for the DoD’s emergency use of Pathogen-Reduced Leukocyte-Depleted Freeze-Dried Plasma manufactured by the Centre de Transfusion Sanguine des Armées (often referred to as French freeze-dried Plasma). That action reflected the importance that both the DoD and the FDA place on efficiently prioritizing and expediting availability of potentially life-saving biological products that are essential to the urgent care of military personnel, especially those in potential battlefield settings. Granting this authorization supported access to this important product and ensures that it will be available if needed. In July 2018, the FDA approved the atropine autoinjector device as a medical countermeasure for chemical nerve agent exposure. This drug-device product was developed in partnership with the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense, and was approved six months ahead of the DoD’s product development schedule. In August 2018, following a priority review, the FDA approved the first prophylactic drug for malaria in over 18 years, tafenoquine (Arakoda). This drug was developed in partnership with the U.S. Army Medical Research and Materiel Command. On October 29, 2018, the FDA issued draft guidance to help foster the development and eventual approval of dried plasma products. Since these types of plasma products do not need to be stored frozen and can be reconstituted and administered quickly they can be used by military personnel in remote areas without freezers and other support equipment. Reviewed by James Ives, M.Psych. (Editor)Nov 5 2018Today, the U.S. Food and Drug Administration and the Department of Defense’s (DoD) Office of Health Affairs signed a Memorandum of Understanding regarding medical product development and assessment. This builds upon the work of both agencies to foster and prioritize the efficient development of safe and effective medical products intended to save the lives of American service members.”We’re extremely grateful to the men and women who defend our nation, often at great personal risk and sacrifice. It’s our honor and duty to support our military personnel by ensuring they have access to safe and effective medical products – especially products that meet the unique needs and settings in which soldiers may require medical treatment,” said FDA Commissioner Scott Gottlieb, M.D. “The FDA has already been working closely with the DoD to identify opportunities to expedite availability of medical products, particularly those products used to treat injuries in battlefield settings. For example, as noted below, the Emergency Use Authorization for French freeze-dried plasma that was issued earlier this year. Our close collaboration with DoD has helped us target and more efficiently address DoD’s immediate product priorities and foster development and review of these products in the most streamlined manner possible. We are looking forward to additional partnership opportunities under the MOU.”The MOU formally establishes the framework under which the DoD and the FDA will implement the law passed by Congress in 2017 for enhanced engagements between the DoD and the FDA. Under the terms of this MOU, the FDA will work closely with the DoD to evaluate how best to foster access to safe and effective medical products that serve the military’s medical needs; give the highest level of attention to and expedite review of priority DoD medical products; provide ongoing technical advice to aid in the rapid development and manufacturing of medical products for use by the military; and examine products currently under development to determine opportunities to streamline review and expedite their availability. The 2017 law also expanded the FDA’s authority to authorize emergency uses of medical products to reduce deaths and severity of injuries caused by chemical, biological, radiological or nuclear (CBRN) agents or agents that may cause, or are otherwise associated with, an imminently life-threatening and specific risk to the U.S. military forces and for other purposes.”This MOU furthers the existing partnership between the Department of Defense and the FDA to equip our military with the best and most innovative military medical support possible,” said Terry M. Rauch, Ph.D., M.P.H., M.B.A., Acting Deputy Assistant Secretary of Defense, Health Readiness Policy & Oversight, DOD. “Our servicemen and women risk their lives protecting our country. Today’s MOU reflects the commitment of the DoD and the FDA to ensure timely access to life-saving medical products for U.S. troops and to continue fostering the development of new innovative medical products that can help ensure the operational readiness of American troops. We look forward to continuing to work with the FDA as we analyze and implement measures to provide the best possible medical products and care to all military personnel – on the battlefield, stationed around the world and at home.””Our enhanced collaboration with our DoD partners has been vital to gaining a better understanding of the health needs of those protecting our country,” said Anna Abram, the FDA’s Deputy Commissioner for Policy, Planning, Legislation and Analysis. “Today’s MOU is a key milestone in implementing a robust and enduring pathway that fulfills our commitment to expedite access to safe and effective medical products for our military personnel.”Related StoriesResearchers improve training modules for future surgeons with 3D printingDisrupting ChIP Assay Technology with New AdvancementsSociologist identifies link between decline in stable manufacturing jobs and reduced fertility ratesThe MOU signed today builds upon the approach that the FDA outlined in 2018 to advance the development and availability of medical products to help save the lives of American military personnel in a work plan developed in close collaboration with the DoD. The MOU reflects the agency’s commitment to working to address the medical needs of military personnel, especially by helping to expedite the development and review of medical products that are a priority for the DoD and to aid in the rapid development and manufacturing of safe and effective medical products for use by the U.S. military. Specifically, the MOU sets forth a framework to implement the 2017 law, which included provisions to allow the Secretary of Defense to request, and the FDA to take, specific actions to expedite the development of medical products, and the review of investigational submissions, applications for approval/licensure, and submissions/notifications for clearance for such medical products to diagnose, prevent, treat or mitigate a specific and life-threatening risk to the U.S.As part of the ongoing and frequent collaborations between the FDA and the DoD, additional steps taken over the past several months include: The FDA and the DoD are committed to the ongoing partnership and are confident that today’s MOU will enhance those efforts to better serve the health care needs of American military personnel.The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.center_img Source:https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm624970.htmlast_img read more

Read More

UCR biomedical professor to investigate how bodys cannabislike molecules influence obesity

first_imgOur work, which will be done on a mouse model, will support the discovery and development of novel therapeutic strategies to safely treat obesity and related metabolic disorders. Currently, a critical barrier to effective treatment of obesity is a lack of reliable therapeutic options.”Nicholas DiPatrizio, assistant professor of biomedical sciences, UCR Reviewed by Alina Shrourou, B.Sc. (Editor)Jul 11 2019More than two-thirds of adults in the United States are overweight or obese. Eating foods containing high levels of fats and sugars — the “Western diet” — can lead to obesity and significantly reduce life expectancy.Nicholas DiPatrizio, an assistant professor of biomedical sciences in the School of Medicine at the University of California, Riverside, has received a five-year grant of more than $1.7 million from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, or NIH, to identify novel gut-brain endocannabinoid signaling pathways that control feeding behavior and become impaired in obesity. Related StoriesNew anti-obesity drug trial set to launch at Alberta Diabetes InstituteUranium toxicity might have caused obesity and diabetes in Kuwait, finds new studyResearchers find link between maternal obesity and childhood cancer in offspringEndocannabinoids are cannabis-like molecules made naturally by the body to regulate a wide variety of physiological processes. As with cannabis, endocannabinoids can enhance feeding behavior. The endocannabinoid system in mice is extremely similar to the one in humans.Recent studies on mice from the DiPatrizio lab have shown that the endocannabinoid system in the gut plays a critical role in gut-brain signaling — especially where feeling satiated is concerned. The system becomes impaired in diet-induced obesity, resulting in the mice steadily gaining weight and not feeling full even after consuming a large amount of food.”We think the endocannabinoid system gets remodeled after exposure to high-energy nutrients and contributes to overeating in diet-induced obesity,” DiPatrizio said. “Our preliminary results support this hypothesis.”DiPatrizio explained that food intake and energy balance are controlled by a dynamic interplay of gut-brain signaling pathways; the molecular underpinnings in these processes and their impairment in obesity, however, remain poorly understood.”What are the specific components in the Western diet that at the molecular level impact gut-brain endocannabinoid system signaling and diet-induced obesity?” he said. “We will work to identify these components.”DiPatrizio, who recently received UCR’s first cannabis grant, will be joined in the research by doctoral students and staff in his lab. Source:University of California – Riversidelast_img read more

Read More

Woman caught urinating in ice cream maker arrested

first_img Related News Metro News 02 Jul 2019 Ice cream brand whips up new fruity flavours for the summer World 15 Jun 2019 Russia’s Putin gives China’s Xi ice cream on his 66th birthday Tech News 08 Jul 2019 US police issue warning on ‘ice cream challenge’ after making another arrest FLORIDA (ANN): A woman who allegedly urinated in an ice cream maker of a store in Florida, United States was arrested last Monday, July 8.Police were notified of the incident when Paul Chiulli, owner of the ice cream parlor, turned over surveillance videos from the store, as per NBC-affiliate WFLA-TV last Tuesday, July 9.The shop was located beside the store of the accused, Jung Soon Wypcha. Chiulli and Wypcha share a common space behind their establishments. Chiulli said he was not aware that Wypcha could access his ice cream parlor.One of the videos shows the woman picking her nose and sticking her hands in the ice cream containers last June 17. She also reportedly opened the freezer which contains the frozen desserts, and spat on the containers in a separate video.center_img Wyphca tried to use the restroom of the shop on June 22 but it turned out to be locked, as per report. Unable to access the toilet, she took a bucket used for churning ice cream and urinated inside it.She emptied out the bucket in a sink that was used to wash ice cream utensils. She then proceeded to place her hands inside the freezer.Wypcha’s actions prompted the store to close and destroy approximately $2,000 (RM8, 220) worth of products to ensure public safety. – Philippines Daily Inquirer/Asia News Network Related News {{category}} {{time}} {{title}}last_img read more

Read More